Global Oral Vaccines Market Growth 2020-2025

  • receipt Report ID : 140344
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 161
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the Oral Vaccines market will register a 7.4%% CAGR in terms of revenue, the global market size will reach $ 3020.1 million by 2025, from $ 2272.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Oral Vaccines, covering the supply chain analysis, impact assessment to the Oral Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Oral Vaccines companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Public

Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Merck

Vabiotech

GSK

Lanzhou Institute

Serum Institute

Sanofi

Bibcol

Valneva

PaxVax

Shanghai United Cell

Tiantan Biological

Bio-Med

Panacea Biotec Ltd

Halfkin Bio-Pharmaceuticals

EuBiologics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Oral Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Oral Vaccines market by identifying its various subsegments.

Focuses on the key global Oral Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Oral Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Oral Vaccines submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Vaccines Consumption 2015-2025

2.1.2 Oral Vaccines Consumption CAGR by Region

2.2 Oral Vaccines Segment by Type

2.2.1 Rotavirus Vaccine

2.2.2 Cholera Vaccine

2.2.3 Oral Polio Vaccine

2.2.4 Others

2.3 Oral Vaccines Consumption by Type

2.3.1 Global Oral Vaccines Consumption Market Share by Type (2015-2020)

2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2015-2020)

2.3.3 Global Oral Vaccines Sale Price by Type (2015-2020)

2.4 Oral Vaccines Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Oral Vaccines Consumption by Application

2.5.1 Global Oral Vaccines Consumption Market Share by Type (2015-2020)

2.5.2 Global Oral Vaccines Value and Market Share by Type (2015-2020)

2.5.3 Global Oral Vaccines Sale Price by Type (2015-2020)

3 Global Oral Vaccines by Company

3.1 Global Oral Vaccines Sales Market Share by Company

3.1.1 Global Oral Vaccines Sales by Company (2018-2020)

3.1.2 Global Oral Vaccines Sales Market Share by Company (2018-2020)

3.2 Global Oral Vaccines Revenue Market Share by Company

3.2.1 Global Oral Vaccines Revenue by Company (2018-2020)

3.2.2 Global Oral Vaccines Revenue Market Share by Company (2018-2020)

3.3 Global Oral Vaccines Sale Price by Company

3.4 Global Oral Vaccines Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Oral Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Oral Vaccines by Regions

4.1 Oral Vaccines by Regions

4.2 Americas Oral Vaccines Consumption Growth

4.3 APAC Oral Vaccines Consumption Growth

4.4 Europe Oral Vaccines Consumption Growth

4.5 Middle East & Africa Oral Vaccines Consumption Growth

5 Americas

5.1 Americas Oral Vaccines Consumption by Countries

5.1.1 Americas Oral Vaccines Consumption by Countries (2015-2020)

5.1.2 Americas Oral Vaccines Value by Countries (2015-2020)

5.2 Americas Oral Vaccines Consumption by Type

5.3 Americas Oral Vaccines Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Oral Vaccines Consumption by Regions

6.1.1 APAC Oral Vaccines Consumption by Regions (2015-2020)

6.1.2 APAC Oral Vaccines Value by Regions (2015-2020)

6.2 APAC Oral Vaccines Consumption by Type

6.3 APAC Oral Vaccines Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Oral Vaccines by Countries

7.1.1 Europe Oral Vaccines Consumption by Countries (2015-2020)

7.1.2 Europe Oral Vaccines Value by Countries (2015-2020)

7.2 Europe Oral Vaccines Consumption by Type

7.3 Europe Oral Vaccines Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Oral Vaccines by Countries

8.1.1 Middle East & Africa Oral Vaccines Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Oral Vaccines Value by Countries (2015-2020)

8.2 Middle East & Africa Oral Vaccines Consumption by Type

8.3 Middle East & Africa Oral Vaccines Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Oral Vaccines Distributors

10.3 Oral Vaccines Customer

11 Global Oral Vaccines Market Forecast

11.1 Global Oral Vaccines Consumption Forecast (2021-2025)

11.2 Global Oral Vaccines Forecast by Regions

11.2.1 Global Oral Vaccines Forecast by Regions (2021-2025)

11.2.2 Global Oral Vaccines Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Oral Vaccines Forecast by Type

11.8 Global Oral Vaccines Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Company Information

12.1.2 Oral Vaccines Product Offered

12.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Merck Latest Developments

12.2 Vabiotech

12.2.1 Company Information

12.2.2 Oral Vaccines Product Offered

12.2.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Vabiotech Latest Developments

12.3 GSK

12.3.1 Company Information

12.3.2 Oral Vaccines Product Offered

12.3.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 GSK Latest Developments

12.4 Lanzhou Institute

12.4.1 Company Information

12.4.2 Oral Vaccines Product Offered

12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Lanzhou Institute Latest Developments

12.5 Serum Institute

12.5.1 Company Information

12.5.2 Oral Vaccines Product Offered

12.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Serum Institute Latest Developments

12.6 Sanofi

12.6.1 Company Information

12.6.2 Oral Vaccines Product Offered

12.6.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Sanofi Latest Developments

12.7 Bibcol

12.7.1 Company Information

12.7.2 Oral Vaccines Product Offered

12.7.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Bibcol Latest Developments

12.8 Valneva

12.8.1 Company Information

12.8.2 Oral Vaccines Product Offered

12.8.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Valneva Latest Developments

12.9 PaxVax

12.9.1 Company Information

12.9.2 Oral Vaccines Product Offered

12.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 PaxVax Latest Developments

12.10 Shanghai United Cell

12.10.1 Company Information

12.10.2 Oral Vaccines Product Offered

12.10.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Shanghai United Cell Latest Developments

12.11 Tiantan Biological

12.11.1 Company Information

12.11.2 Oral Vaccines Product Offered

12.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Tiantan Biological Latest Developments

12.12 Bio-Med

12.12.1 Company Information

12.12.2 Oral Vaccines Product Offered

12.12.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Bio-Med Latest Developments

12.13 Panacea Biotec Ltd

12.13.1 Company Information

12.13.2 Oral Vaccines Product Offered

12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Panacea Biotec Ltd Latest Developments

12.14 Halfkin Bio-Pharmaceuticals

12.14.1 Company Information

12.14.2 Oral Vaccines Product Offered

12.14.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Halfkin Bio-Pharmaceuticals Latest Developments

12.15 EuBiologics

12.15.1 Company Information

12.15.2 Oral Vaccines Product Offered

12.15.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 EuBiologics Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Oral Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Rotavirus Vaccine

Table 5. Major Players of Cholera Vaccine

Table 6. Major Players of Oral Polio Vaccine

Table 7. Major Players of Others

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Oral Vaccines Consumption Market Share by Type (2015-2020)

Table 10. Global Oral Vaccines Revenue by Type (2015-2020) ($ million)

Table 11. Global Oral Vaccines Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Oral Vaccines Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Oral Vaccines Consumption Market Share by Application (2015-2020)

Table 15. Global Oral Vaccines Value by Application (2015-2020)

Table 16. Global Oral Vaccines Value Market Share by Application (2015-2020)

Table 17. Global Oral Vaccines Sale Price by Application (2015-2020)

Table 18. Global Oral Vaccines Sales by Company (2017-2019) (M Doses)

Table 19. Global Oral Vaccines Sales Market Share by Company (2017-2019)

Table 20. Global Oral Vaccines Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Oral Vaccines Revenue Market Share by Company (2017-2019)

Table 22. Global Oral Vaccines Sale Price by Company (2017-2019)

Table 23. Global Oral Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Oral Vaccines Products Offered

Table 25. Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Oral Vaccines Consumption by Regions 2015-2020 (M Doses)

Table 27. Global Oral Vaccines Consumption Market Share by Regions 2015-2020

Table 28. Global Oral Vaccines Value by Regions 2015-2020 ($ Millions)

Table 29. Global Oral Vaccines Value Market Share by Regions 2015-2020

Table 30. Americas Oral Vaccines Consumption by Countries (2015-2020) (M Doses)

Table 31. Americas Oral Vaccines Consumption Market Share by Countries (2015-2020)

Table 32. Americas Oral Vaccines Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Oral Vaccines Value Market Share by Countries (2015-2020)

Table 34. Americas Oral Vaccines Consumption by Type (2015-2020) (M Doses)

Table 35. Americas Oral Vaccines Consumption Market Share by Type (2015-2020)

Table 36. Americas Oral Vaccines Consumption by Application (2015-2020) (M Doses)

Table 37. Americas Oral Vaccines Consumption Market Share by Application (2015-2020)

Table 38. APAC Oral Vaccines Consumption by Countries (2015-2020) (M Doses)

Table 39. APAC Oral Vaccines Consumption Market Share by Countries (2015-2020)

Table 40. APAC Oral Vaccines Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Oral Vaccines Value Market Share by Regions (2015-2020)

Table 42. APAC Oral Vaccines Consumption by Type (2015-2020) (M Doses)

Table 43. APAC Oral Vaccines Consumption Market Share by Type (2015-2020)

Table 44. APAC Oral Vaccines Consumption by Application (2015-2020) (M Doses)

Table 45. APAC Oral Vaccines Consumption Market Share by Application (2015-2020)

Table 46. Europe Oral Vaccines Consumption by Countries (2015-2020) (M Doses)

Table 47. Europe Oral Vaccines Consumption Market Share by Countries (2015-2020)

Table 48. Europe Oral Vaccines Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Oral Vaccines Value Market Share by Countries (2015-2020)

Table 50. Europe Oral Vaccines Consumption by Type (2015-2020) (M Doses)

Table 51. Europe Oral Vaccines Consumption Market Share by Type (2015-2020)

Table 52. Europe Oral Vaccines Consumption by Application (2015-2020) (M Doses)

Table 53. Europe Oral Vaccines Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Oral Vaccines Consumption by Countries (2015-2020) (M Doses)

Table 55. Middle East & Africa Oral Vaccines Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Oral Vaccines Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Oral Vaccines Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Oral Vaccines Consumption by Type (2015-2020) (M Doses)

Table 59. Middle East & Africa Oral Vaccines Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Oral Vaccines Consumption by Application (2015-2020) (M Doses)

Table 61. Middle East & Africa Oral Vaccines Consumption Market Share by Application (2015-2020)

Table 62. Oral Vaccines Distributors List

Table 63. Oral Vaccines Customer List

Table 64. Global Oral Vaccines Consumption Forecast by Countries (2021-2025) (M Doses)

Table 65. Global Oral Vaccines Consumption Market Forecast by Regions

Table 66. Global Oral Vaccines Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Oral Vaccines Value Market Share Forecast by Regions

Table 68. Global Oral Vaccines Consumption Forecast by Type (2021-2025) (M Doses)

Table 69. Global Oral Vaccines Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Oral Vaccines Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Oral Vaccines Value Market Share Forecast by Type (2021-2025)

Table 72. Global Oral Vaccines Consumption Forecast by Application (2021-2025) (M Doses)

Table 73. Global Oral Vaccines Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Oral Vaccines Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Oral Vaccines Value Market Share Forecast by Application (2021-2025)

Table 76. Merck Product Offered

Table 77. Merck Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 78. Merck Main Business

Table 79. Merck Latest Developments

Table 80. Merck Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 81. Vabiotech Product Offered

Table 82. Vabiotech Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 83. Vabiotech Main Business

Table 84. Vabiotech Latest Developments

Table 85. Vabiotech Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 86. GSK Product Offered

Table 87. GSK Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 88. GSK Main Business

Table 89. GSK Latest Developments

Table 90. GSK Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 91. Lanzhou Institute Product Offered

Table 92. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 93. Lanzhou Institute Main Business

Table 94. Lanzhou Institute Latest Developments

Table 95. Lanzhou Institute Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 96. Serum Institute Product Offered

Table 97. Serum Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 98. Serum Institute Main Business

Table 99. Serum Institute Latest Developments

Table 100. Serum Institute Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 101. Sanofi Product Offered

Table 102. Sanofi Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 103. Sanofi Main Business

Table 104. Sanofi Latest Developments

Table 105. Sanofi Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 106. Bibcol Product Offered

Table 107. Bibcol Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Bibcol Main Business

Table 109. Bibcol Latest Developments

Table 110. Bibcol Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 111. Valneva Product Offered

Table 112. Valneva Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 113. Valneva Main Business

Table 114. Valneva Latest Developments

Table 115. Valneva Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 116. PaxVax Product Offered

Table 117. PaxVax Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 118. PaxVax Main Business

Table 119. PaxVax Latest Developments

Table 120. PaxVax Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 121. Shanghai United Cell Product Offered

Table 122. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 123. Shanghai United Cell Main Business

Table 124. Shanghai United Cell Latest Developments

Table 125. Shanghai United Cell Basic Information, Company Total Revenue (in $ million), Oral Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 126. Tiantan Biological Product Offered

Table 127. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 128. Tiantan Biological Main Business

Table 129. Tiantan Biological Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 130. Tiantan Biological Latest Developments

Table 131. Bio-Med Product Offered

Table 132. Bio-Med Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 133. Bio-Med Main Business

Table 134. Bio-Med Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 135. Bio-Med Latest Developments

Table 136. Panacea Biotec Ltd Product Offered

Table 137. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 138. Panacea Biotec Ltd Main Business

Table 139. Panacea Biotec Ltd Latest Developments

Table 140. Panacea Biotec Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 141. Halfkin Bio-Pharmaceuticals Product Offered

Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 143. Halfkin Bio-Pharmaceuticals Main Business

Table 144. Halfkin Bio-Pharmaceuticals Latest Developments

Table 145. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 146. EuBiologics Product Offered

Table 147. EuBiologics Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 148. EuBiologics Main Business

Table 149. EuBiologics Latest Developments

Table 150. EuBiologics Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Oral Vaccines

Figure 2. Oral Vaccines Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Oral Vaccines Consumption Growth Rate 2015-2025 (M Doses)

Figure 5. Global Oral Vaccines Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Rotavirus Vaccine

Figure 7. Product Picture of Cholera Vaccine

Figure 8. Product Picture of Oral Polio Vaccine

Figure 9. Product Picture of Others

Figure 10. Global Oral Vaccines Consumption Market Share by Type (2015-2020)

Figure 11. Global Oral Vaccines Value Market Share by Type (2015-2020)

Figure 12. Oral Vaccines Consumed in Public

Figure 13. Global Oral Vaccines Market: Public (2015-2020) (M Doses)

Figure 14. Global Oral Vaccines Market: Public (2015-2020) ($ Millions)

Figure 15. Oral Vaccines Consumed in Private

Figure 16. Global Oral Vaccines Market: Private (2015-2020) (M Doses)

Figure 17. Global Oral Vaccines Market: Private (2015-2020) ($ Millions)

Figure 18. Global Oral Vaccines Consumption Market Share by Application (2015-2020)

Figure 19. Global Oral Vaccines Value Market Share by Application (2015-2020)

Figure 20. Global Oral Vaccines Sales Market Share by Company in 2017

Figure 21. Global Oral Vaccines Sales Market Share by Company in 2019

Figure 22. Global Oral Vaccines Revenue Market Share by Company in 2017

Figure 23. Global Oral Vaccines Revenue Market Share by Company in 2019

Figure 24. Global Oral Vaccines Sale Price by Company in 2019

Figure 25. Global Oral Vaccines Consumption Market Share by Regions 2015-2020

Figure 26. Global Oral Vaccines Value Market Share by Regions 2015-2020

Figure 27. Americas Oral Vaccines Consumption 2015-2020 (M Doses)

Figure 28. Americas Oral Vaccines Value 2015-2020 ($ Millions)

Figure 29. APAC Oral Vaccines Consumption 2015-2020 (M Doses)

Figure 30. APAC Oral Vaccines Value 2015-2020 ($ Millions)

Figure 31. Europe Oral Vaccines Consumption 2015-2020 (M Doses)

Figure 32. Europe Oral Vaccines Value 2015-2020 ($ Millions)

Figure 33. Middle East & Africa Oral Vaccines Consumption 2015-2020 (M Doses)

Figure 34. Middle East & Africa Oral Vaccines Value 2015-2020 ($ Millions)

Figure 35. Americas Oral Vaccines Consumption Market Share by Countries in 2019

Figure 36. Americas Oral Vaccines Value Market Share by Countries in 2019

Figure 37. Americas Oral Vaccines Consumption Market Share by Type in 2019

Figure 38. Americas Oral Vaccines Consumption Market Share by Application in 2019

Figure 39. United States Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 40. United States Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 41. Canada Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 42. Canada Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 43. Mexico Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 44. Mexico Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 45. APAC Oral Vaccines Consumption Market Share by Countries in 2019

Figure 46. APAC Oral Vaccines Value Market Share by Regions in 2019

Figure 47. APAC Oral Vaccines Consumption Market Share by Type in 2019

Figure 48. APAC Oral Vaccines Consumption Market Share by Application in 2019

Figure 49. China Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 50. China Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 51. Japan Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 52. Japan Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 53. Korea Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 54. Korea Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 55. Southeast Asia Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 56. Southeast Asia Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 57. India Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 58. India Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 59. Australia Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 60. Australia Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 61. Europe Oral Vaccines Consumption Market Share by Countries in 2019

Figure 62. Europe Oral Vaccines Value Market Share by Countries in 2019

Figure 63. Europe Oral Vaccines Consumption Market Share by Type in 2019

Figure 64. Europe Oral Vaccines Consumption Market Share by Application in 2019

Figure 65. Germany Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 66. Germany Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 67. France Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 68. France Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 69. UK Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 70. UK Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 71. Italy Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 72. Italy Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 73. Russia Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 74. Russia Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 75. Middle East & Africa Oral Vaccines Consumption Market Share by Countries in 2019

Figure 76. Middle East & Africa Oral Vaccines Value Market Share by Countries in 2019

Figure 77. Middle East & Africa Oral Vaccines Consumption Market Share by Type in 2019

Figure 78. Middle East & Africa Oral Vaccines Consumption Market Share by Application in 2019

Figure 79. Egypt Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 80. Egypt Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 81. South Africa Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 82. South Africa Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 83. Israel Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 84. Israel Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 85. Turkey Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 86. Turkey Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 87. GCC Countries Oral Vaccines Consumption Growth 2015-2020 (M Doses)

Figure 88. GCC Countries Oral Vaccines Value Growth 2015-2020 ($ Millions)

Figure 89. Global Oral Vaccines Consumption Growth Rate Forecast (2021-2025) (M Doses)

Figure 90. Global Oral Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 91. Americas Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 92. Americas Oral Vaccines Value 2021-2025 ($ Millions)

Figure 93. APAC Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 94. APAC Oral Vaccines Value 2021-2025 ($ Millions)

Figure 95. Europe Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 96. Europe Oral Vaccines Value 2021-2025 ($ Millions)

Figure 97. Middle East & Africa Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 98. Middle East & Africa Oral Vaccines Value 2021-2025 ($ Millions)

Figure 99. United States Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 100. United States Oral Vaccines Value 2021-2025 ($ Millions)

Figure 101. Canada Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 102. Canada Oral Vaccines Value 2021-2025 ($ Millions)

Figure 103. Mexico Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 104. Mexico Oral Vaccines Value 2021-2025 ($ Millions)

Figure 105. Brazil Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 106. Brazil Oral Vaccines Value 2021-2025 ($ Millions)

Figure 107. China Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 108. China Oral Vaccines Value 2021-2025 ($ Millions)

Figure 109. Japan Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 110. Japan Oral Vaccines Value 2021-2025 ($ Millions)

Figure 111. Korea Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 112. Korea Oral Vaccines Value 2021-2025 ($ Millions)

Figure 113. Southeast Asia Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 114. Southeast Asia Oral Vaccines Value 2021-2025 ($ Millions)

Figure 115. India Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 116. India Oral Vaccines Value 2021-2025 ($ Millions)

Figure 117. Australia Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 118. Australia Oral Vaccines Value 2021-2025 ($ Millions)

Figure 119. Germany Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 120. Germany Oral Vaccines Value 2021-2025 ($ Millions)

Figure 121. France Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 122. France Oral Vaccines Value 2021-2025 ($ Millions)

Figure 123. UK Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 124. UK Oral Vaccines Value 2021-2025 ($ Millions)

Figure 125. Italy Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 126. Italy Oral Vaccines Value 2021-2025 ($ Millions)

Figure 127. Russia Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 128. Russia Oral Vaccines Value 2021-2025 ($ Millions)

Figure 129. Spain Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 130. Spain Oral Vaccines Value 2021-2025 ($ Millions)

Figure 131. Egypt Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 132. Egypt Oral Vaccines Value 2021-2025 ($ Millions)

Figure 133. South Africa Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 134. South Africa Oral Vaccines Value 2021-2025 ($ Millions)

Figure 135. Israel Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 136. Israel Oral Vaccines Value 2021-2025 ($ Millions)

Figure 137. Turkey Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 138. Turkey Oral Vaccines Value 2021-2025 ($ Millions)

Figure 139. GCC Countries Oral Vaccines Consumption 2021-2025 (M Doses)

Figure 140. GCC Countries Oral Vaccines Value 2021-2025 ($ Millions)

Figure 141. Merck Oral Vaccines Market Share (2018-2020)

Figure 142. Vabiotech Oral Vaccines Market Share (2018-2020)

Figure 143. GSK Oral Vaccines Market Share (2018-2020)

Figure 144. Lanzhou Institute Oral Vaccines Market Share (2018-2020)

Figure 145. Serum Institute Oral Vaccines Market Share (2018-2020)

Figure 146. Sanofi Oral Vaccines Market Share (2018-2020)

Figure 147. Bibcol Oral Vaccines Market Share (2018-2020)

Figure 148. Valneva Oral Vaccines Market Share (2018-2020)

Figure 149. PaxVax Oral Vaccines Market Share (2018-2020)

Figure 150. Shanghai United Cell Oral Vaccines Market Share (2018-2020)

Figure 151. Tiantan Biological Oral Vaccines Market Share (2018-2020)

Figure 152. Bio-Med Oral Vaccines Market Share (2018-2020)

Figure 153. Panacea Biotec Ltd Oral Vaccines Market Share (2018-2020)

Figure 154. Halfkin Bio-Pharmaceuticals Oral Vaccines Market Share (2018-2020)

Figure 155. EuBiologics Oral Vaccines Market Share (2018-2020)